蝌蚪窝

header-logo
Research Collaborate Lab Hall
headshot

Bronwen E Shaw, MD, PhD

Professor; Scientific Director CIBMTR

view provider profile

Locations

  • Froedtert Hospital
  • Clinical Cancer Center - Froedtert Hospital

Specialties

  • Hematology
  • 蝌蚪窝 Oncology

Languages

  • English

Clinical Cancer Center - Froedtert Hospital

Education

  • MD - Doctor of Medicine
  • PhD

Biography

Dr. Shaw received her MD (MBChB) from the University of Cape Town, South Africa in 1993. All of her subsequent postgraduate haematology specialist training was completed in London, UK where she also received her PhD in Clinical Sciences and Immunology from University College London in 2004. Her PhD was entitled Understanding the immunogenetic and clinical factors which influence the outcome of haematopoietic stem cell transplantation using unrelated donors.

Research Interests

Prior to taking up her position at the CIBMTR and MCW, Dr. Shaw was a Consultant Haematologist specializing in Stem Cell Transplantation and Survivorship issues at the Royal Marsden Hospital in Sutton, UK. She simultaneously held the position of Chief 蝌蚪窝 Officer at Anthony Nolan, the UK’s national unrelated donor registry. In this position she had oversight of the donor research activities and the medical operations of the organization. She also held a senior scientific role, with direct supervision of several PhD and MD students working in the area of immunogenetics, donor selection, and the donor experience.

Publications

  • (Shaffer BC, Al Malki MM, Jimenez AMJ, Stanek J, Bo-Subait S, Logan BR, Kou J, Leckrone E, Stefanski HE, Spellman SR, Malmberg C, Askar M, Cusatis R, Modi D, Khimani F, Hamadani M, Maiers M, Cook R, Ballen K, Bolaños-Meade J, Rao U, Milner J, Abboud R, Jamieson K, Carrum G, Dholaria B, Hogan WJ, Reshef R, Kosuri S, Loren A, Larkin K, Arai S, Qayed M, Choi SW, Broglie L, Auletta JJ, Shaw BE, Devine SM, Gooptu M.) Am J Hematol. 2026 Aug 31 PMID: 42674730 SCOPUS ID: 2-s2.0-105048940816 08/31/2026

  • (Bashey A, Lee SJ, Devine SM, Shaw BE, Dehn JG, Pidala JA, Hogan WJ.) Blood Adv. 2026 Aug 28 PMID: 42664501 08/28/2026

  • (Bashey A, Logan B, Hill L, Symons H, Farhadfar N, Grunwald MR, Pidala J, Dehn JG, Brunstein C, Arai S, Leifer E, He N, Shaw BE, Juckett M, Devine S, Uberti J, Westervelt P, Srour SA, Pusic I, Vasu S, Hayes-Lattin B, Ciurea SO, Horowitz MM, Lee SJ, Hogan WJ.) Blood Adv. 2026 Aug 25;10(16):5543-5552 PMID: 42263667 PMCID: PMC13482518 SCOPUS ID: 2-s2.0-105047220932 06/10/2026

  • (Jimenez Jimenez AM, Stanek J, Logan BR, Leckrone E, Stefanski HE, Auletta JJ, Spellman SR, Malmberg C, Askar M, Cusatis RN, Shaffer BC, Modi D, Khimani F, Gooptu M, Hamadani M, Maiers M, Bo-Subait S, Bolaños-Meade J, Rao U, Milner J, Abboud R, Jamieson KJ, Carrum G, Dholaria B, Hogan WJ, Reshef R, Kosuri S, Cook RJ, Ballen K, Loren AW, Larkin K, Arai S, Qayed M, Choi SW, Broglie L, Shaw BE, Devine SM, Al Malki MM.) Blood Adv. 2026 Aug 19 PMID: 42616616 08/19/2026

  • (Auletta JJ, Urbano-Ispizua A, Maziarz RT, Shaw BE, Sureda A, Vasu S, Porter DL.) Transplant Cell Ther. 2026 Aug 12 PMID: 42586370 PMCID: PMC13537614 SCOPUS ID: 2-s2.0-105049335730 08/12/2026

  • (Auletta JJ, Stanek J, Bo-Subait S, Al Malki MM, Cook RJ, Gooptu M, Shaffer BC, Jimenez Jimenez AM, Modi D, Hill JA, Huppler AR, Kou J, Cusatis RN, Broglie L, Shaw BE, Stefanski HE, Spellman SR, Devine SM.) Blood Adv. 2026 Jul 14 PMID: 42448319 07/15/2026

  • (Switzer GE, Bruce JG, Shaw BE, Kuniyil V, Varni JW, Butler BJ, Erickson C, Mussetter A, Neutzling A, Abdel-Azim H, Aguayo-Hiraldo P, Anderson EJ, Aquino VM, Boone K, Boulad F, Chewning JH, Cooper J, Dahlberg A, Dvorak CC, Galvez-Silva J, Haight AE, Hoag JA, Hudspeth M, Jacobsohn D, Kasow KA, Kitko CL, Krishnamurti L, Madden L, Miller HK, Morales E, Olson TS, Pawlowska AB, Prasad VK, Quigg TC, Scaradavou A, Shah NC, Shenoy S, Terwilliger NB, Wiener L, Yanik GA, Yu LC, Pulsipher MA.) Transplant Cell Ther. 2026 Jul;32(7):885.e1-885.e14 PMID: 41997298 PMCID: PMC13479314 SCOPUS ID: 2-s2.0-105038259426 04/18/2026

  • (Shaffer BC, Shaw BE.) Curr Opin Immunol. 2026 Jun;100:102783 PMID: 42060959 PMCID: PMC13210405 SCOPUS ID: 2-s2.0-105037085733 05/01/2026

  • (Pidala J, Logan B, Lee SJ, Shaw BE, Devine S, Ciurea SO, Horowitz M, He N, Pusic I, Srour SA, Arai S, Juckett M, Uberti J, Hill L, Vasu S, Hogan WJ, Hayes-Lattin B, Westervelt P, Bashey A, Farhadfar N, Grunwald MR, Leifer E, Symons H, Saad A, Vogel J, Erickson C, Buck K, Dehn JG.) Transplant Cell Ther. 2026 Jun;32(6):678-688 PMID: 41547399 PMCID: PMC13086071 SCOPUS ID: 2-s2.0-105034344999 01/18/2026

  • (Cusatis R, Kou J, Bupp C, Mattila D, Abboud R, Arai S, Bolaños Meade J, Carrum G, Dholaria B, Fareh F, Hamadani M, Hogan WJ, Jamieson K, Jimenez Jimenez AM, Khimani F, Kelkar AH, Kosuri S, Larkin KT, Al Malki MM, McCurdy SR, Milner J, Modi D, Reshef R, Shaffer BC, Shanmugasundaram K, Rao U, Auletta JJ, Devine SM, Logan BR, Shaw BE.) JAMA Netw Open. 2026 May 01;9(5):e2610839 PMID: 42084866 PMCID: PMC13147192 SCOPUS ID: 2-s2.0-105038059420 05/05/2026

  • (Liberio N, Allbee-Johnson M, Ahn KW, Moskop A, Phelan R, Shaw BE, Page KM, Schultz KR, Phillips CL, Mehta PA, Qayed M, Sharma A, Lipsitt AE, Symons H, Bolaños-Meade J, Kharbanda S, Dvorak CC, Kapoor N, Doherty EE, Chavan RS, Broglie L.) J Clin Oncol. 2026 Apr 10;44(11):1003-1015 PMID: 41740085 PMCID: PMC13162296 SCOPUS ID: 2-s2.0-105034223811 02/25/2026

  • (Cusatis R, Kapfhammer M, Rein L, Szabo A, Reed-Thryselius S, Phelan R, Bingen K, Runaas L, Shaw BE, Flynn KE.) J Cancer Surviv. 2026 Jan 09 PMID: 41511743 PMCID: PMC13044967 SCOPUS ID: 2-s2.0-105027391304 01/09/2026

Publications of from the

© 2026 蝌蚪窝.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 蝌蚪窝 (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. MCW maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

MCW's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.